Prevention Is Better Than the Cure: Risk Management of COVID-19

被引:64
|
作者
McAleer, Michael [1 ,2 ,3 ,4 ,5 ]
机构
[1] Asia Univ, Dept Finance, Taichung 41354, Taiwan
[2] Univ Sydney, Business Sch, Discipline Business Analyt, Sydney, NSW 2006, Australia
[3] Erasmus Univ, Erasmus Sch Econ, Econometr Inst, NL-3062 Rotterdam, Netherlands
[4] Univ Complutense Madrid, Dept Econ Anal & ICAE, Madrid 28040, Spain
[5] Yokohama Natl Univ, Inst Adv Sci, Yokohama, Kanagawa 2408501, Japan
基金
澳大利亚研究理事会;
关键词
COVID-19; SARS; MERS; risk management; vaccines; cures; clinical trials;
D O I
10.3390/jrfm13030046
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
A novel coronavirus was reported to the World Health Organization (WHO) in China on 31 December 2019. The WHO named the disease COVID-19 on 11 February 2020. As of 26 February 2020, the disease has been detected on all continents, except for Antarctica. Daily updates on COVID-19 since early February 2020 have made headline news worldwide for much of 2020. This editorial evaluates risk management based on the Global Health Security (GHS) Index of global health security capabilities in 195 countries. The GHS Index lists the countries best prepared for an epidemic or pandemic. COVID-19 is compared with two related coronavirus epidemics, SARS and MERS, in terms of the number of reported human infections, deaths, countries, major country clusters, timelines, and the likelihood of discovering a safe, effective, and approved vaccine.
引用
收藏
页数:5
相关论文
共 50 条